The current state of the art and future trends in RAS-targeted cancer therapies | Nature Reviews Clinical Oncology
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth | Science Advances
Pancreatic Cancer Tumor Markers | GeneTex
Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins | eLife
Pancreatic Cancer Tumor Markers | GeneTex
Tumor Markers - Pathology Made Simple
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Targeting RAS signalling pathways in cancer therapy | Nature Reviews Cancer
Role of RAS signaling in ovarian cancer | F1000Research
Influence of oncogenic K-Ras on xenograft tumor growth and cancer stem... | Download Scientific Diagram
Tumormarker in der Gastroenterologie ISBN: 978-3-89599-223-0
p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo | PNAS
Role of RAS signaling in ovarian cancer | F1000Research
Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials - ScienceDirect
Emerging strategies to target RAS signaling in human cancer therapy | Journal of Hematology & Oncology | Full Text
The effects of mutant Ras proteins on the cell signalome | Cancer and Metastasis Reviews
Vom Biomarker zur Therapie: RAS
Frontiers | RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
cancer genetics, tumor marker and targeted therapy in cancer | PPT
KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer - ScienceDirect
Tumor Suppression of Ras GTPase-Activating Protein RASA5 through Antagonizing Ras Signaling Perturbation in Carcinomas - ScienceDirect
